文献速递卫生政策与健康促进免疫规划

评估疫苗时对广泛人群健康视角的接受与应用

Acceptance and application of a broad population health perspective when evaluating vaccine.
PubMed 文献 · Vaccine · 2022-05-05

该研究通过文献与卫生技术评估决策的战略综述、瑞典利益相关方在线圆桌讨论及对瑞典COVID-19疫苗接种价值的基本估算,探讨疫苗卫生经济学分析中相关后果类型及HTA机构实际考虑的后果。结果显示,除群体效应外,人群更广泛经济后果通常未纳入疫苗经济评价,且接种者生产损失与照护者健康损失也并非总被考虑;采用社会视角纳入更广泛人群后果时,COVID-19疫苗每剂估计价值为744–956欧元。

要点

  • 除群体效应外,人群更广泛经济后果通常未纳入疫苗经济评价。
  • 接种者生产损失与照护者健康损失并非总被考虑。
  • 社会视角下COVID-19疫苗每剂估计价值744–956欧元。

核心结论

  • 除群体效应外,人群更广泛经济后果通常未纳入疫苗经济评价,且所选视角可对分析结果产生重大影响。

研究设计与样本

  • 研究包括对瑞典及其他国家文献与HTA决策的战略综述、与瑞典利益相关方的在线圆桌讨论,以及对瑞典COVID-19疫苗接种价值的基本估算。

主要发现

  • 除群体效应外,人群更广泛经济后果通常未纳入疫苗经济评价。
  • 接种者生产损失与照护者健康损失并非总被考虑。
  • 采用纳入更广泛人群后果的社会视角时,COVID-19疫苗每剂估计价值为744–956欧元。

关键数值与推荐

  • 采用纳入更广泛人群后果的社会视角时,COVID-19疫苗每剂估计价值为744–956欧元。

临床怎么用

  • 提供完整适当的疫苗接种价值图景对高效配置资源、激励疫苗开发及展示延迟实施新疫苗决策的成本具有重要性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The traditional health economic analysis is limited to estimating the impact on the treated patient. As vaccines are usually aimed at preventing infectious diseases, they may be associated with additional values for the non-treated wider population. Although there are valid reasons for treating vaccines differently, and a wide support for a broader perspective in the literature (i.e., beyond the net costs and health gain related to the outcome for the vaccinated individual), it remains unclear to what extent the Health Technology Assessment (HTA) agencies accept and apply a broader perspective. The purpose of this study is to examine and discuss what type of consequences are relevant for a health economic analysis of vaccines and which consequences are considered by HTA agencies. The study includes a strategic review of literature and HTA decisions in Sweden and other countries, online round-table discussions with stakeholders in Sweden, and a basic estimation of the value of a COVID-19 vaccination in Sweden. The study shows that, other than herd effect, broader economic consequences for the population are generally not included in the economic evaluation of vaccines. Also, all economic consequences for the treated patient (production loss) and caregiver (health loss) are not always considered. The perspective chosen can have a major impact on the outcome of the analysis. A vaccine for COVID-19 is estimated to provide a value of €744-€956 per dose when using a societal perspective including broader consequences for the population. Providing a complete and appropriate picture of the value of vaccination is of importance to allocate resources efficiently, to provide incentives for vaccine development, and to show the cost of delaying decisions to implement a new vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Persson U, Olofsson S, Althin R, et al. Acceptance and application of a broad population health perspective when evaluating vaccine. Vaccine. 2022. PMID: 35525728. doi:10.1016/j.vaccine.2022.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。